Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a painful, dose-limiting adverse effect of commonly used chemotherapeutic agents. The purpose of this exploratory study was to evaluate the efficacy and safety of mirogabalin in patients with moderate to severe CIPN during chem...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Sonoko Misawa, Tadamichi Denda, Sho Kodama, Takuji Suzuki, Yoichi Naito, Takahiro Kogawa, Mamoru Takada, Tomoki Suichi, Kazuhito Shiosakai, Satoshi Kuwabara, on behalf of the MiroCIP study group
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2023-11-01
Ráidu:BMC Cancer
Fáttát:
Analgesia
Cancer
Chemotherapy
Chemotherapy-induced peripheral neuropathy
Mirogabalin
Neurotoxicity
Liŋkkat:https://doi.org/10.1186/s12885-023-11560-4

Interneahtta

https://doi.org/10.1186/s12885-023-11560-4

Geahča maid